Cases & Deals

  • Home
  • Practices
  • Celgene pursues patent infringement litigation against KV Pharmaceutical concerning Ritalin LA®

Share

Celgene pursues patent infringement litigation against KV Pharmaceutical concerning Ritalin LA®

September 2007

Client(s) Celgene Corporation

Jones Day represents Celgene Corporation in a Hatch-Waxman patent infringement case concerning a generic version of the branded drug Ritalin LA®.

Celgene Corporation et al. v. KV Pharmaceutical Co., Case No. 2-07-cv-04819 (D.N.J. 2007) (Judge Wigenton)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.